Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. Mar 16, 2023; 15(3): 153-162
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.153
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.153
Figure 1 The patient inclusion process in this study.
GVB: Gastric varices bleeding; EVHT: Endoscopic variceal histoacryl injection therapy; PPI: Proton pump inhibitor; APG: Aluminium phosphate gel.
Figure 2 The causes of rebleeding are related to glue discharge ulcers and venous bleeding.
A: After 2 wk of endoscopic treatment, the gastric fundus shows a draining ulcer; B: Fundic vein bleeding after 3 wk of endoscopic treatment, there was gastric fundic drainage, formation of an ulcer, and bleeding; C: Varices that did not disappear completely were spurting bleeding after 14 d of endoscopic therapy.
- Citation: Zeng HT, Zhang ZL, Lin XM, Peng MS, Wang LS, Xu ZL. Aluminum phosphate gel reduces early rebleeding in cirrhotic patients with gastric variceal bleeding treated with histoacryl injection therapy. World J Gastrointest Endosc 2023; 15(3): 153-162
- URL: https://www.wjgnet.com/1948-5190/full/v15/i3/153.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i3.153